Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance

Jazz Pharmaceuticals (JAZZ) Tops Q2 EPS by 10c; Guides In-Line

August 3, 2022 4:29 PM EDT

Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q2 EPS of $4.30, $0.10 better than the analyst estimate of $4.20. Revenue for the quarter came in at $932.9 million versus the consensus estimate of $902.46 million.

GUIDANCE:

Jazz Pharmaceuticals sees FY2022 EPS of $16.70-$17.71, versus the consensus of $17.09.... More